Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yan-rong Shuai"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Emerging evidence shows that FAT atypical cadherin 1 (FAT1) mutations occur in lymphoma and are associated with poorer overall survival. Considering that diffuse large B cell lymphoma (DLBCL) is the category of lymphoma with the highest inci
Externí odkaz:
https://doaj.org/article/72c3a5788cf044f098d6751f5970792a
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 734-738 (2023)
Acute myeloid leukemia (AML) is a large class of heterogeneous hematological malignancies with the highest incidence rate in acute leukemia. Its pathogenesis is still unclear, which may be related to genetics. According to the latest AML NCCN guideli
Externí odkaz:
https://doaj.org/article/6e1f491e6ae14a1bba69a6db00a8bdb2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yan Zeng, Yi Su, Yan‑Rong Shuai, Yi Wang, Hai Yi, Li Fu, Rui Deng, Fang‑Yi Fan, Xiao‑Juan Miao, Guang‑Cui He
Publikováno v:
Experimental and Therapeutic Medicine
Acute myeloid leukemia (AML) remains difficult to cure due to its drug tolerance and refractoriness. Immunotherapy is a growing area of cancer research, which has been applied for the treatment of numerous types of cancer, including leukemia. The pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c4a07f1c8e3ab1c9b2c948f14783de
https://doi.org/10.3892/etm.2017.4620
https://doi.org/10.3892/etm.2017.4620
Autor:
Guang‑Cui He, Fang‑Yi Fan, Li Fu, Rui Deng, Ling Qiu, Hai Yi, Hao‑Ping Sun, Yi‑Lan Liu, Ye‑Cheng Li, Yan Zeng, Xiao‑Juan Miao, Si‑Han Lai, Yi Wang, Yan‑Rong Shuai, Guo‑Shun Li, Yi Su
Publikováno v:
Molecular and Clinical Oncology. 3:1233-1238
Epstein-Barr virus (EBV)-related non-Hodgkin's lymphoma (NHL) represents a major problem in hematological clinical studies due to its drug tolerance and refractoriness. EBV infection is a key factor driving the process of tumor growth. Immune therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::441015825aeeeb923322890a3f29a029
https://doi.org/10.3892/mco.2015.646
https://doi.org/10.3892/mco.2015.646
Autor:
RUI DENG, FANG-YI FAN, HAI YI, LI FU, YAN ZENG, YI WANG, XIAO-JUAN MIAO, YAN-RONG SHUAI, GUANG-CUI HE, YI SU
Publikováno v:
Experimental & Therapeutic Medicine; Aug2017, Vol. 14 Issue 2, p1081-1085, 5p
Autor:
RUI DENG, HAI YI, YI-LAN LIU, FANG-YI FAN, LI FU, YE-CHENG LI, SI-HAN LAI, XIAO-JUAN MIAO, YAN-RONG SHUAI, GUANG-CUI HE, YI WANG, YAN ZENG, HAO-PING SUN, LING QIU, YI SU, GUO-SHUN LI
Publikováno v:
Molecular & Clinical Oncology; Nov/Dec2015, Vol. 3 Issue 6, p1233-1238, 6p